Clinical trials
Phase 1 Fragile X Syndrome trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital Medical Center, Cincinnati | 3 |
| Stanford University | 2 |
| Guido A. Davidzon, MD, SM | 1 |
| Healx AI | 1 |
| Institute for Neurodegenerative Disorders | 1 |
| Novartis Pharmaceuticals | 1 |
| Seaside Therapeutics, Inc. | 1 |
| University of California, Davis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fragile X Syndrome | 11 |
| Intellectual Disability | 2 |
| Alzheimer Disease | 1 |
| Angelman Syndrome | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Autism Spectrum Disorder | 1 |
| Cognitive Dysfunction | 1 |
| Down Syndrome | 1 |
| Huntington Disease | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.